GE HealthCare: The Image Of More Upside Is Very Real
Summary
- GE HealthCare Technologies has shown promising performance, with a 12% stock increase since June, outperforming the S&P 500's 2.9% rise.
- Despite some revenue declines in key segments, the PDx segment's 12.5% growth and overall profitability improvements are encouraging.
- Management's revised guidance suggests a positive outlook, with expected EPS growth and improved EBIT margins, indicating strong future potential.
- GE HealthCare Technologies remains attractively priced compared to peers, with manageable leverage, justifying a continued 'buy' rating.
FinkAvenue
By most accounts, things have been going quite well for shareholders of GE HealthCare Technologies (NASDAQ:GEHC). I have followed the company for a long time. I even analyzed it when it was part of the former conglomerate
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
